Search

CAMBRIDGE: Be Biopharma, Inc. has issued the following news release: Be Biopharma, Inc. ('Be Bio'), a clinical-stage company pioneering engineered B Cell Medicines (BCMs), today announced two key updates at [...]

LUND: Hansa Biopharma AB has issued the following press release: Hansa Biopharma, 'Hansa' (Nasdaq Stockholm: HNSA) and Genethon, a pioneer and a leader in gene therapy research and development for [...]

SAN DIEGO: Regen BioPharma, Inc. has issued the following news release: Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial [...]

LYON: OSIVAX has issued the following news release: Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that the first participant has [...]

MUMBAI: POPVAX has issued the following news release: PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational protein design, is pleased to announce [...]

SOUTH SAN FRANCISCO, Calif: Sutro Biopharma, Inc. has issued the following news release: Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format [...]

GAITHERSBURG, Md.: LakeShore Biopharma Co., Ltd. has issued the following news release: LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ('LakeShore Biopharma' or the 'Company'), a global biopharmaceutical company dedicated to discovering, [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: Systemic lupus erythematosus is a long-lasting autoimmune disorder that can impact various areas of the body. Lupus arises [...]

LOS ANGELES: Immix Biopharma, Inc. has issued the following news release: Immix Biopharma, Inc. ('ImmixBio', 'Company', 'We' or 'Us', 'IMMX') (Nasdaq: IMMX), a clinical-stage biopharmaceutical company developing cell therapies for [...]

CAMBRIDGE: Artax Biopharma has issued the following press release: Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces the acceptance of two [...]

NEW YORK: Spine BioPharma, Inc., announced the completion of enrollment of its U.S. Phase 3 clinical trial of SB-01 For Injection (SB-01). The Phase 3 MODEL trial enrolled 417 patients [...]

BRUSSELS: UCB (Euronext Brussels: UCB) and Biogen Inc. (NASDAQ: BIIB) today announced positive topline results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol, a novel Fc-free anti-CD40L drug [...]

SUZHOU: CD (Suzhou) Biopharma Co., Ltd. has issued the following press release: CD (Suzhou) Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New [...]

HOUSTON: Kiromic BioPharma, Inc. announced that the Deltacel-01 Safety Monitoring Committee has unanimously voted in favor of proceeding with the expansion phase of the Deltacel-01 clinical trial. This trial is [...]

HOUSTON: Kiromic BioPharma, Inc.announces that the University of Arizona Cancer Center has been activated as the fifth clinical trial site in the Deltacel-01 Phase 1 trial evaluating Deltaceltm (KB-GDT-01), Kiromic's [...]

FOSTER CITY: Gilead Sciences, Inc. (Nasdaq: GILD) today announced the results of an interim analysis from a second pivotal Phase 3 clinical trial investigating the use of the company's twice-yearly [...]

YONGIN: GC Biopharma has issued the following press release: GC Biopharma announced that its collaborative project for Fabry treatment 'LA-GLA' (GC1134A/HM15421) with Hanmi Pharmaceutical has received Investigational New Drug (IND) [...]

SAN CARLOS: Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced positive topline results from the [...]

CRANBURY: Palatin Technologies, Inc. has issued the following news release: Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of [...]

COSTA MESA, Calif: AiViva Biopharma has issued the following news release: AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has fully enrolled and completed dosing the last patient [...]

CAMBRIDGE: Artax Biopharma has issued the following press release: Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces the completion of patient [...]

CHENGDU: WestGene has issued the following press release: WestGene Biopharma is proud to announce that its therapeutic mRNA cancer vaccine WGc-043 has received dual IND approval from China's National Medical [...]

CAMBRIDGE: Artax Biopharma has issued the following news release: Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces the closure of an [...]

SEATTLE: Umoja Biopharma, Inc. has issued the following news release: Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of [...]

ROCKVILLE: OS THERAPIES, INC. has issued the following news release: OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage oncology-focused immunotherapy company developing cancer vaccines and antibody drug conjugate (ADC) therapeutic candidates, [...]

EMERYVILLE, Calif: Dynavax Technologies has issued the following news release: Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the first participant [...]

SHANGHAI: Clover Biopharma has issued the following news release: Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save [...]

HOUSTON: KIROMIC BIOPHARMA, INC. has issued the following news release: Kiromic BioPharma, Inc. (OTCQB: KRBP) ('Kiromic' or the 'Company') reports follow-up results from the second, third and fourth patients enrolled [...]

CRANBURY: Palatin Technologies, Inc. has issued the following news release: Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of [...]

HOUSTON: Kiromic BioPharma, Inc. (OTCQB: KRBP) (Kiromic or the Company) reports favorable six-month follow-up results from the first patient enrolled in the Deltacel-01 Phase 1 clinical trial. This trial is [...]

HOUSTON: Kiromic BioPharma, Inc. announces that UPMC in Pittsburgh, Pennsylvania has been activated as the fourth clinical trial site in the Deltacel-01 Phase 1 trial evaluating Deltaceltm (KB-GDT-01), Kiromic's allogeneic, [...]

CAMBRIDGE: Be Biopharma, Inc., presents results from new preclinical research demonstrating the production of active ALP by a BCM, which highlights BCMs as a potential treatment for Hypophosphatasia (HPP). Researchers [...]

LAWRENCEVILLE: IMUNON, Inc., a clinical-stage drug development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, today announced that DM Clinical Research in Philadelphia is the first site activated [...]

ROCKVILLE, Md. and SEOUL, South Korea: HanAll Biopharma has issued the following news release: HanAll Biopharma Co., Ltd. (KRX: 009420. KS), a global biopharmaceutical company committed to discovering and developing [...]

CRANBURY: Palatin Technologies, Inc., a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that the U.S. Food and Drug [...]

HAYWARD: ARCUS BIOSCIENCES has issued the following news release: Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, [...]

HOUSTON: Kiromic BioPharma, Inc. (OTCQB: KRBP) ('Kiromic' or the 'Company') announces consistent favorable safety, tolerability, and efficacy from follow-up visits of the first cohort of three patients enrolled in the [...]

SHANGHAI: Clover Biopharma has issued the following news release: Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save [...]

CRANBURY: Palatin Technologies, Inc. has issued the following news release: Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of [...]

HOUSTON: Kiromic BioPharma, Inc. (Kiromic) reported early efficacy results showing tumor stabilization in the third patient enrolled in the Company's Deltacel-01 Phase 1 clinical trial. Deltacel-01 is evaluating Deltacel (KB-GDT-01), [...]

LYON: Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating viruses, announced that all participants have completed their final visit in the Phase 2a clinical trial [...]

ATHENS: Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect against serious infectious [...]

ATHENS: Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect against serious infectious [...]

HOUSTON: Kiromic BioPharma, Inc., reports early efficacy results showing primary lung tumor stabilization and the complete disappearance of brain metastases in the second patient in the Company's Deltacel-01 Phase 1 [...]

FOSTER CITY: Gilead Sciences, Inc, announces results from the Phase 2 clinical study evaluating the investigational combination of islatravir, an investigational nucleoside reverse transcriptase translocation inhibitor, and lenacapavir, a first-in-class [...]

HOUSTON: Kiromic BioPharma, Inc., announced that Virginia Oncology Associates, PC (Norfolk, Virginia) has been activated as the second clinical trial site in the Phase 1 Deltacel-01 trial evaluating Deltaceltm (KB-GDT-01), [...]

NEW YORK: Medidata, a Dassault Systemes company and leading provider of clinical trial solutions to the life sciences industry, and Sanofi Vaccines, announced a collaboration to harness Medidata eCOA to [...]

BEDMINSTER: Matinas BioPharma announces alignment with the U.S. Food and Drug Administration on the design of a single Phase 3 registration trial of MAT2203 in patients with invasive aspergillosis who [...]

BEDMINSTER: Matinas BioPharma announces alignment with the U.S. Food and Drug Administration on the design of a single Phase 3 registration trial of MAT2203 in patients with invasive aspergillosis who [...]

HOUSTON: Kiromic BioPharma, Inc. announces continued encouraging clinical findings from the most recent follow-up visit of the first patient enrolled in Deltacel-01, the Company's Phase 1 clinical trial evaluating Deltaceltm [...]